Yumi Konagaya
Postdoctoral Associate · Weill Cornell Medicine
I worked as a graduate student in the lab of Michiyuki Matsuda at Kyoto University, Japan, where I developed a transgenic mouse line expressing a novel FRET-based reporter for AMP-activated protein kinase (AMPK) and found tissue- and cell-type specific activation of AMPK in vivo. After I received my Ph.D. from Kyoto University in 2019, I moved to the United States for my postdoctoral training in the lab of Tobias Meyer at Stanford University and Weill Cornell Medicine, USA. In the Meyer Lab, I have been studying the proliferation-quiescence decision using a live-cell reporter system for E2F and cyclin-dependent kinase (CDK) activities. I will be starting my own lab as a principal investigator at the RIKEN Center for Biosystems Dynamics Research (BDR), Kobe, Japan, in January 2024.
I worked as a graduate student in the lab of Michiyuki Matsuda at Kyoto University, Japan, where I developed a transgenic mouse line expressing a novel FRET-based reporter for AMP-activated protein kinase (AMPK) and found tissue- and cell-type specific activation of AMPK in vivo. After I received my Ph.D. from Kyoto University in 2019, I moved to the United States for my postdoctoral training in the lab of Tobias Meyer at Stanford University and Weill Cornell Medicine, USA. In the Meyer Lab, I have been studying the proliferation-quiescence decision using a live-cell reporter system for E2F and cyclin-dependent kinase (CDK) activities. I will be starting my own lab as a principal investigator at the RIKEN Center for Biosystems Dynamics Research (BDR), Kobe, Japan, in January 2024.
Where curiosity meets discovery.
Where curiosity meets discovery.
I launch my lab at RIKEN Center for Biosystems Dynamics Research (BDR), Kobe, Japan in January 2024!
I launch my lab at RIKEN Center for Biosystems Dynamics Research (BDR), Kobe, Japan in January 2024!